Zydus launches Semaglutide injection under three brand names in India

Zydus launches Semaglutide injection under three brand names in India


Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI) had earlier provided its approval for manufacturing and marketing Semaglutide injection for the treatment of both Type 2 Diabetes Mellitus and Obesity indications.

Unlike current treatment options, which often require patients to purchase multiple single-dose pens as they progressively titrate their dosage, Zydus offers an innovative reusable multi-dose novel pen device. This advancement will enable clinicians and patients to conveniently select and administer different dose strengths from a single pen, thereby improving adherence, enhancing convenience, and significantly lowering the overall therapy cost. Zydus’ Semaglutide injection will be available in 15mg/3ml cartridge and will be manufactured at Zydus Biotech Park, Ahmedabad. The average monthly cost of the treatment will be approximately Rs. 2,200.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 21 2026 | 10:04 AM IST



Source link

Zydus launches Semaglutide injection under three brand names in India

Sun Pharma launches semaglutide injection under brand names Noveltreat and Sematrinity in India


Sun Pharmaceutical Industries announced the launch of its semaglutide injection under the brand names Noveltreat and Sematrinity in India, in all strengths.

Noveltreat is indicated for chronic weight management in adults as an adjunct to a reduced calorie diet & increased physical activity and is available in five dose strengths 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, and 2.4 mg/0.75 mL.

Sematrinity is indicated for treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet & exercise and is available in two dose strengths 2 mg/1.5 mL and 4 mg/3 mL.

 

Priced significantly lower than the innovator brand, weekly therapy costs, from initiation to the highest dose, range from approximately Rs 900 to Rs 2,000 for Noveltreat and Rs 750 to Rs 1,300 for Sematrinity, supporting greater affordability.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 21 2026 | 9:50 AM IST



Source link

Zydus launches Semaglutide injection under three brand names in India

ALkem Laboratories' Daman facility gets GMP compliance certificate


Alkem Laboratories announced that it has received a Good Manufacturing Practices (GMP) compliance certificate from the Malta Medicines Authority for its manufacturing facility located in Daman, India.

The certificate is valid for a period of three years from the date of inspection being 09th December, 2025.

The inspection was conducted between 5 December 2025 and 9 December 2025. Following the inspection the facility was granted the GMP compliance certificate, subject to three major observations along with a few minor observations noted by the authority.

Alkem Laboratories is engaged in the pharmaceutical business with global operations. The company is engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products.

 

The companys consolidated net profit rose 2% to Rs 653.53 crore in Q3 FY26, compared with Rs 640.79 crore posted in Q3 FY25. Net sales jumped 10.7% YoY to Rs 3,736.82 crore in the quarter ended 31 December 2025.

The scrip rose 0.32% to end at Rs 5,257.75 on the BSE.

Powered by Capital Market – Live News



Source link

Zydus launches Semaglutide injection under three brand names in India

Alps Industries reports consolidated net profit of Rs 62.04 crore in the December 2025 quarter


Reported sales nil

Net profit of Alps Industries reported to Rs 62.04 crore in the quarter ended December 2025 as against net loss of Rs 16.05 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 21 2026 | 9:04 AM IST



Source link

Zydus launches Semaglutide injection under three brand names in India

Reganto Enterprises standalone net profit declines 72.76% in the December 2025 quarter


Sales decline 71.88% to Rs 49.34 crore

Net profit of Reganto Enterprises declined 72.76% to Rs 2.64 crore in the quarter ended December 2025 as against Rs 9.69 crore during the previous quarter ended December 2024. Sales declined 71.88% to Rs 49.34 crore in the quarter ended December 2025 as against Rs 175.48 crore during the previous quarter ended December 2024.

ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales49.34175.48 -72 OPM %8.117.97 PBDT4.0013.98 -71 PBT4.0013.96 -71 NP2.649.69 -73

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 21 2026 | 9:04 AM IST



Source link

Gold price dips ₹10 to ₹1,48,900; silver down ₹100, trades at ₹2,54,900

Gold price dips ₹10 to ₹1,48,900; silver down ₹100, trades at ₹2,54,900



Gold Price Today: The price of 24-carat gold fell ₹10 in early trade on Saturday, with ten grams of the precious metal trading at ₹1,48,900, according to the GoodReturns website. The price of silver also dropped by ₹100, with one kilogram of the precious metal selling at ₹2,54,900.

 


The price of 22-carat gold decreased by ₹10, with ten grams of the yellow metal selling at ₹1,36,540. 

 


The price of ten grams of 24-carat gold stood at ₹1,48,900 in Mumbai, Kolkata, Bengaluru and Hyderabad and ₹1,52,190 in Chennai. 

 


In Delhi, the price of ten grams of 24-carat gold stood at ₹1,49,050. 

 


   


In Mumbai, the price of ten grams of 22-carat gold was ₹1,36,540, the same as in Kolkata, Bengaluru, Hyderabad, and ₹1,39,510 in Chennai. 

 

In Delhi, the price of ten grams of 22-carat gold stood at ₹1,36,690.   


  


The price of one kilogram of silver in Delhi, Kolkata, and Mumbai stood at ₹2,54,900. 

 


The price of one kilogram of silver in Chennai stood at ₹2,59,900. 

 


US gold prices fell by 1.8 per cent as the dollar strengthened on a report that the United States ​will deploy extra troops in West Asia, fanning ​concerns of higher oil prices, inflation, and with it, elevated interest rates.

 


Spot ‌gold fell 1.8 per cent to $4,563.64 per ounce as of 2:14 p.m. ET (1814 GMT) after earlier rising 1 per cent. US gold futures for April delivery were 0.7 per cent lower at $4,574.90.

 


Spot silver fell 4.8 per cent to $69.39. Platinum dropped 0.9 per cent to $1,953.18 and palladium slipped 1.6 per cent to $1,423.59. All three ‌metals were on ​track for weekly declines.

 


(with inputs from Reuters) 



Source link

YouTube
Instagram
WhatsApp